Page 106 - IMO-1-1
P. 106

Innovative Medicines & Omics                                           SARS-CoV-2 inhibition by quinolines



            negative interactions were noted between D187 and E166.   for its involvement in hydration site interactions. Finally,
            Furthermore, the Maestro (v13.6.122) 2D visualization   negatively charged interactions were observed with E47
            unveiled significant positively charged interactions with   and E166.
            R188 and polar interactions with residues H164, S144,   The favorable interactions observed between the novel
            and  S46.  The  secondary  amine  outside  the  quinoline   compounds and the majority of the subpockets (Figure 8)
            nucleus can act as a hydrogen bond acceptor with H41   coupled with their replication of pharmacophoric
            of the catalytic site. In contrast, the carbon atom between   groups previously described in the literature suggest
            the tertiary amine and the alkyne group at the end of the   their potential efficacy in inhibiting SARS-CoV-2 M .
                                                                                                           pro
            molecule can act as a hydrogen bond donor to the residues   Specifically, compound  Q4b demonstrated a significant
            of the adjacent subpockets.
                                                               3D arrangement within the catalytic site, effectively
              Regarding compound  Q2b (Figure  7E  and  F), it   encompassing  the  additional  subpockets.  This  finding
            displayed hydrophobic interactions with C44 and C145   implies  that  the  compound  could  exhibit  enhanced
            and a polar interaction with H41. Those hydrophobic   effectiveness in subsequent experimental trials.
            interactions occur through the quinoline nucleus and
            the alkyne portion at the end of the chain. Furthermore,   Comparing the docking of target compounds with the
            it formed a negatively charged bond with E166, and the   reference compounds, we can discern parallels within  the
            2D visualization revealed potential polar interactions with   interactions  occurring  at  the  catalytic  site  residue  and
            H163, H164, B51, and T45, which also participated in a   the ligand. For instance, molnupiravir (Figure 9A and B)
            hydrogen bond. Residues T26, S144, and S46 were also   displayed a hydrogen bond interaction with H41, C44,
            indicated as potential polar interactions in addition to   and C145, accompanied by polar interactions involving
            the mentioned residues. The secondary carbon adjacent   T45 and hydrophobic interactions with M49. In addition,
            to the nitrogen of the quinoline nucleus can also act as a   as  elucidated  by Maestro (v13.6.122),  other  interactions
            hydrogen donor to the oxygen of the G166 residue.  can also be discerned, including polar interactions
                                                               with H164, N142, S144, S46, T25, T190, and Q189, as
              In the case of compound  Q3a (Figure  7A  and  B), we   well as hydrophobic interactions with M165 and L27.
            observed hydrophobic  interactions  with  A191, F140, and   Furthermore, positively charged interactions with R188
            M165. Moreover, polar bonds were formed with H41 and   and negatively charged interactions with B187 were noted.
            H172 and a hydrogen bond with F140. In addition, the
            final amine portion can act as a hydrogen bond donor and   In the case of mefloquine (Figure 9C and D), a hydrogen
            perform salt bridge-type interactions with E166. The 2D   bond interaction was established with H41. In contrast,
            representation revealed potential hydrophobic interactions   lopinavir, used as a positive control, exhibited hydrogen
                                                                                  pro
            with M165, C145, and L141. Furthermore, negatively   bond formation with M , specifically involving residues
            charged interactions were identified between E166 and B187.  H41, H163, and C145 (Figure 9E and F).
              Compound  Q3b  (Figure  7G  and  H)  displayed     Mefloquine, a drug utilized for malaria treatment,
            polar interactions with H41 and H163, as well as T45.   has a partially understood mechanism, potentially acting
                                                                                                    70
            Hydrophobic interactions were also observed with C44   on the ribosomes of  Plasmodium falciparum. Although
            and C145. In addition, a positively charged bond was   it belongs to the aminoquinoline class proposed in this
            formed with the R188 residue. Moreover, potential polar   research, mefloquine serves as a negative control. This
            interactions  were  revealed  with  Q189,  N51,  S46,  and   designation stems from its similar structural core that
            S144, in addition to the mentioned residues. Hydrophobic   lacks the requisite pharmacophoric groups for effective
                                                                 pro
            interactions were also identified with M165, F140, and   M  inhibition. Conversely, molnupiravir, a prodrug in
            L141. In addition, the program suggested negatively   the polymerase inhibitor class, interferes competitively
            charged interactions with E166 and B187.           with the viral RNA-dependent RNA polymerase (RdRp)
                                                               post-cellular uptake. 71,72  Despite suggestions of its efficacy
              In conclusion, compound  Q4b (Figure  7I  and  J)
            exhibited polar interactions with H41 and H164, along with   against COVID-19, its targeted action on a distinct viral
                                                               enzyme designates it as another negative control, as the
            S46. Hydrophobic interactions were established with C44   study’s aim is to inhibit a viral protease.
            and C145, as well as Y54. Finally, positively charged bonds
            were  formed  with  the  R188  residue.  Maestro  unveiled   Lopinavir,  a  protease  inhibitor  for  human
            potential polar interactions with Q189, N51, N142, T45,   immunodeficiency virus (HIV) management, operates
            T26, H163, and S144, apart from the mentioned residues.   through competitive inhibition of viral protease, blocking
            Notable hydrophobic interactions were identified with   substrate cleavage and thus immature viral particle
            M165 and L27. The G143 residue was also highlighted   formation.  Its effectiveness extends beyond HIV to other
                                                                       73

            Volume 1 Issue 1 (2024)                        100                               doi: 10.36922/imo.3442
   101   102   103   104   105   106   107   108   109   110   111